Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-004276·Cowen Financial Products LLC
Schedule 13G ownership disclosure
Stoke Therapeutics Inc
Common Stock · CUSIP: 86150R107
Event date: 2025-06-30
- Filing-level shares
- 3,173,258
- Percent of class
- 5.8%
- Cowen Financial Products LLC
Shares: 3,173,258 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-004276
- Form type
- SCHEDULE 13G/A
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership